The reduced amount of H1R binding reported in the frontal and temporal areas of AD patients has been correlated with the severity of their cognitive symptoms, suggesting that a decrease in H1R expression contributes to the observed cognitive deficits in AD patients due to changes in the histaminergic neurotransmission (Higuchi et al., 2000). This evidence concerns the gene HRH1 and Alzheimer disease.